Therapeutic nanoparticles in clinics and under clinical evaluation.
about
Using natural language processing techniques to inform research on nanotechnologyRecent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryPotential applications and human biosafety of nanomaterials used in nanomedicineRETRACTED: Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors.High-density lipoproteins for the systemic delivery of short interfering RNA.Update on current and potential nanoparticle cancer therapiesDifferential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticlesAnticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance.Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical TranslationFlow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods.Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy.Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy.Nanotechnology applications in thoracic surgery.Fluorescent ampicillin analogues as multifunctional disguising agents against opsonization.Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyLocal hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk.Image-driven pharmacokinetics: nanomedicine concentration across space and time.Lung cancer nanomedicine: potentials and pitfalls.Biodegradable polymers for targeted delivery of anti-cancer drugs.Applicability of avidin protein coated mesoporous silica nanoparticles as drug carriers in the lung.Methodological considerations when conducting in vitro, air-liquid interface exposures to engineered nanoparticle aerosols.Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.Molecular Cancer Imaging with Polymeric Nanoassemblies: From Tumor Detection to Theranostics.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Horizon scan of nanomedicinal products.Long-term monitoring for nanomedicine implants and drugs.The role of nanotechnology in the treatment of viral infections.PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections.Composite iron oxide-Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors.An annotated corpus with nanomedicine and pharmacokinetic parameters.Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.Biological impact assessment of nanomaterial used in nanomedicine. introduction to the NanoTEST project.Exploiting cancer's antioxidative weakness through p53 with nanotoxicology.The potential of multi-compound nanoparticles to bypass drug resistance in cancer.Targeting microbial biofilms: current and prospective therapeutic strategies.
P2860
Q26801074-06300198-BC68-4DB1-B0EA-571DDC5053E9Q28085438-7F0924E3-0305-4AF7-9A1E-3580EBF2AA89Q32944368-90611A3B-B801-443D-BA19-4F2D40DCE634Q33583711-61C09528-616B-462E-90D5-67E3D02AFFE9Q33706579-F582E68A-2B72-4882-AC56-B7BF9D3486A8Q33786171-C5EA91FE-745B-4074-BC85-2D7B4D4DF366Q33874239-ED2EF150-337C-4241-944F-E79A9B8B3B33Q33968741-4CF13D51-AE35-4DF8-9D65-A57425D34615Q35189961-8C7F38A6-99FC-4FA2-993C-76E840E81DD1Q35438759-747BEB63-413B-4C10-8962-ABDDED24CE40Q35821937-83386BB2-6A82-4F0F-BB9D-95DA6F6A5BFDQ36131470-E15D19C9-95F2-4780-862C-99C205525288Q36395984-15DC760A-5880-43B3-9F70-2B4E006F7FA8Q36926018-1DF37346-8837-4050-A429-5D851580E5A9Q37021105-9A4C9039-5E15-4BCE-A33C-D187A544E6A2Q37033809-DD5C1ACA-AF1A-4011-99E7-9074A263E9C7Q37086820-43DDF0A2-D0FD-486D-8DB3-DDDE951D9DF3Q37324832-1073BB6E-3FD5-40B6-A987-05C41FACB7ACQ38495022-BDBFBD6E-2BD1-4AA0-86DD-C9DDD3EF2E5CQ38558104-865192FC-A37A-4E09-B6DB-58642C8C7662Q38586888-400A9716-B9FD-4ED8-9018-D27E40BD11C5Q38608622-7F492C63-330E-45DC-B22B-B559E7E0CD13Q38777436-F4A37AAB-81EC-4FD5-B195-FA77F22EA1ABQ38782781-40C8E15A-4003-4BC2-9A0C-20E39D9E23F7Q38819505-5A006AC0-9DA6-4FC5-B67D-E7F24DE9BF37Q38853466-08DD332F-3A94-4EF4-9CC5-C8E2663ED2F3Q38897360-E63226B0-7B4A-4B00-BBFB-BEA6E20B5067Q38980390-3D24BFA2-F979-4B99-AFF8-E03F580922EFQ38981743-679171F2-7366-4AE6-BCD6-C0E5B79D4BE7Q39037527-531A9480-EF93-4437-AD8C-F53D14E45181Q39952097-5688A094-60FF-46EE-B0AE-B2E97A6336FCQ40106774-207D6CA9-4D87-47CD-A9DF-DC1523C2ABFFQ40145387-DF1F470B-DC62-434D-8B75-00259F9811BCQ41385642-E78552C2-3AFF-4870-A6A8-B194388E77BDQ42656502-77297C3C-44C3-446E-B30B-1817AF6065FBQ44794686-16C7D6B5-F401-4083-99BE-FB7355E6A047Q46463088-9A85FD00-EA17-4F9D-B4B1-3C1868AF7C1EQ46899218-76C9E69D-5D75-4E54-BCDE-CA836270DCB2Q47114290-65D5A122-033B-453C-8516-41E91A317DB4Q47637669-D235C6E8-7C50-44D6-9429-B7F469EE37E2
P2860
Therapeutic nanoparticles in clinics and under clinical evaluation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic nanoparticles in clinics and under clinical evaluation.
@en
type
label
Therapeutic nanoparticles in clinics and under clinical evaluation.
@en
prefLabel
Therapeutic nanoparticles in clinics and under clinical evaluation.
@en
P2093
P2860
P356
P1433
P1476
Therapeutic nanoparticles in clinics and under clinical evaluation.
@en
P2093
Catherine A Schütz
Heinz Mueller
Lucienne Juillerat-Jeanneret
NanoImpactNet Consortium
P2860
P304
P356
10.2217/NNM.13.8
P577
2013-03-01T00:00:00Z